Bortezomib-Based Consolidation/Maintenance Therapy for Multiple Myeloma: A Meta-Analysis of Randomized Controlled Trials

被引：0
|
作者：
Zhang, Shijia [1 ]
Wang, Yucai [2 ]
Datta, Yvonne [1 ]
Bachanova, Veronika [1 ]
Cooley, Sarah [1 ]
机构：
[1] Univ Minnesota, Dept Med, Div Hematol Oncol & Transplantat, Box 736 UMHC, Minneapolis, MN 55455 USA
[2] Mayo Clin, Div Hematol, Rochester, MN USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-113533
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3293
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Bortezomib-based consolidation or maintenance therapy for multiple myeloma: a meta-analysis
    Shijia Zhang
    Amit A. Kulkarni
    Beibei Xu
    Haitao Chu
    Taxiarchis Kourelis
    Ronald S. Go
    Michael L. Wang
    Veronika Bachanova
    Yucai Wang
    Blood Cancer Journal, 10
  • [2] Bortezomib-based consolidation or maintenance therapy for multiple myeloma: a meta-analysis
    Zhang, Shijia
    Kulkarni, Amit A.
    Xu, Beibei
    Chu, Haitao
    Kourelis, Taxiarchis
    Go, Ronald S.
    Wang, Michael L.
    Bachanova, Veronika
    Wang, Yucai
    BLOOD CANCER JOURNAL, 2020, 10 (03)
  • [3] Single-agent bortezomib or bortezomib-based regimens as consolidation therapy after autologous hematopoietic stem cell transplantation in multiple myeloma: a meta-analysis of randomized controlled trials
    Gao, Minjie
    Yang, Guang
    Han, Ying
    Kong, Yuanyuan
    Wu, Huiqun
    Tao, Yi
    Zhan, Fenghuang
    Shi, Jumei
    Wu, Xiaosong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (08): : 12202 - 12210
  • [4] Lenalidomide Maintenance Therapy In Multiple Myeloma: A Meta-analysis Of Randomized Trials
    Singh, Preet Paul
    Kumar, Shaji K.
    LaPlant, Betsy R.
    Gertz, Morie A.
    Dispenzieri, Angela
    Bergsagel, P. Leif
    Lacy, Martha Q.
    Singh, Siddharth
    Roy, Vivek
    Buadi, Francis K.
    Dingli, David
    Kyle, Robert
    Rajkumar, S. Vincent
    Kapoor, Prashant
    BLOOD, 2013, 122 (21)
  • [5] Bortezomib-based vs non-bortezomib-based post-transplantation treatment in multiple myeloma patients: a systematic review and meta-analysis of Phase III randomized controlled trials
    Liu, Xiaoping
    He, Colin K.
    Meng, Xiangyu
    He, Li
    Li, Kaili
    Liang, Qing
    Shao, Liang
    Liu, Shangqin
    ONCOTARGETS AND THERAPY, 2015, 8 : 1459 - 1469
  • [6] Efficacy of maintenance or consolidation therapy for multiple myeloma based on proteasome inhibitors: a meta-analysis
    Dan Wu
    Feiqing Wang
    Xu Yang
    Bo Yang
    Juan Chen
    Jinyang Cheng
    Bo Wei
    Xiaoshuang Yuan
    Tingting Tian
    Zhenhua Liu
    Zhixu He
    Yang Liu
    Yanju Li
    Discover Oncology, 16 (1)
  • [7] Bortezomib for patients with previously untreated multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
    Zeng, Zhiyong
    Lin, Junfang
    Chen, Junmin
    ANNALS OF HEMATOLOGY, 2013, 92 (07) : 935 - 943
  • [8] Bortezomib for patients with previously untreated multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
    Zhiyong Zeng
    Junfang Lin
    Junmin Chen
    Annals of Hematology, 2013, 92 : 935 - 943
  • [9] Bortezomib-Containing Regimens for Multiple Myeloma Maintenance Therapy: a Meta-Analysis
    Wang, Yucai
    Zhang, Wenwen
    Yang, Fang
    Guan, Xiaoxiang
    Kothari, Neil
    Chang, Victor
    Wang, Michael
    BLOOD, 2014, 124 (21)
  • [10] BORTEZOMIB-BASED THERAPY IN FRAIL MULTIPLE MYELOMA PATIENTS
    Antonioli, E.
    Staderini, M.
    Nozzoli, C.
    Bacchiarri, F.
    Barone, F.
    Grieco, P.
    Coltro, G.
    Guarrera, A.
    Messeri, M.
    Bosi, A.
    HAEMATOLOGICA, 2017, 102 : 132 - 132
12345